UBS O'Connor’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Buy |
79,723
+6,375
| +9% | +$86.3K | 0.06% | 188 |
|
|
2025
Q1 | $1.16M | Buy |
73,348
+45,280
| +161% | +$719K | 0.04% | 161 |
|
|
2024
Q4 | $346K | Sell |
28,068
-3,000
| -10% | -$36.9K | 0.01% | 288 |
|
|
2024
Q3 | $376K | Sell |
31,068
-28,863
| -48% | -$350K | 0.01% | 345 |
|
|
2024
Q2 | $701K | Buy |
59,931
+1,457
| +2% | +$17K | 0.02% | 336 |
|
|
2024
Q1 | $755K | Sell |
58,474
-127,694
| -69% | -$1.65M | 0.02% | 299 |
|
|
2023
Q4 | $1.6M | Buy |
+186,168
| New | +$1.6M | 0.05% | 208 |
|